These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 33124475)

  • 61. COVID-19 Vaccine Hesitancy.
    Price S
    Tex Med; 2021 Jan; 117(1):42-44. PubMed ID: 33641116
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COVID-19 vaccination hesitancy and challenges to mass vaccination.
    Chau CYC
    Hong Kong Med J; 2021 Oct; 27(5):377-379. PubMed ID: 34657836
    [No Abstract]   [Full Text] [Related]  

  • 63. Association of Race/Ethnicity With Likeliness of COVID-19 Vaccine Uptake Among Health Workers and the General Population in the San Francisco Bay Area.
    Grumbach K; Judson T; Desai M; Jain V; Lindan C; Doernberg SB; Holubar M
    JAMA Intern Med; 2021 Jul; 181(7):1008-1011. PubMed ID: 33783471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Misrepresentation about vaccines that are scaring women.
    Moodley J; Khaliq OP; Mkhize PZ
    Afr J Prim Health Care Fam Med; 2021 Jun; 13(1):e1-e2. PubMed ID: 34212737
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Planning for a COVID-19 Vaccination Program.
    Schaffer DeRoo S; Pudalov NJ; Fu LY
    JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
    [No Abstract]   [Full Text] [Related]  

  • 66. Vaccine hesitancy due to vaccine country of origin, vaccine technology, and certification.
    Dror AA; Daoud A; Morozov NG; Layous E; Eisenbach N; Mizrachi M; Rayan D; Bader A; Francis S; Kaykov E; Barhoum M; Sela E
    Eur J Epidemiol; 2021 Jul; 36(7):709-714. PubMed ID: 34037927
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The mad leading the blind: Perceptions of the vaccine-refusal movement among Australians who support vaccination.
    Rozbroj T; Lyons A; Lucke J
    Vaccine; 2019 Sep; 37(40):5986-5993. PubMed ID: 31451326
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vaccination hesitancy among women of reproductive age in resource-challenged settings: a cause for public health concern.
    Murewanhema G
    Pan Afr Med J; 2021; 38():336. PubMed ID: 34285758
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 70. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring Communication Strategies to Encourage COVID-19 Vaccination: Motivation-Based Message Appeals, Incidental Emotions, and Risk Perception.
    Yang C
    Health Commun; 2023 Oct; 38(9):1731-1743. PubMed ID: 35067103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Wolynn T; Hermann C
    Nat Immunol; 2021 Sep; 22(9):1068-1070. PubMed ID: 34429551
    [No Abstract]   [Full Text] [Related]  

  • 73. Strategies for addressing vaccine hesitancy - A systematic review.
    Jarrett C; Wilson R; O'Leary M; Eckersberger E; Larson HJ;
    Vaccine; 2015 Aug; 33(34):4180-90. PubMed ID: 25896377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Communication, Health Literacy and a Systems Approach for Mitigating the COVID-19 Pandemic: The Case for Massive Vaccine Roll-out in Israel.
    Levin-Zamir D
    J Health Commun; 2020 Oct; 25(10):816-818. PubMed ID: 33719884
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Petersen MB; Bor A; Jørgensen F; Lindholt MF
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292869
    [TBL] [Abstract][Full Text] [Related]  

  • 76. People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.
    Bearth A; Berthold A; Siegrist M
    PLoS One; 2022; 17(2):e0263351. PubMed ID: 35108313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout.
    Pandey A; Sah P; Moghadas SM; Mandal S; Banerjee S; Hotez PJ; Galvani AP
    J Glob Health; 2021 Jun; 11():03083. PubMed ID: 34221355
    [No Abstract]   [Full Text] [Related]  

  • 78. Using Best Practices to Address COVID-19 Vaccine Hesitancy: The Case for the Motivational Interviewing Approach.
    Gabarda A; Butterworth SW
    Health Promot Pract; 2021 Sep; 22(5):611-615. PubMed ID: 33966471
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.
    Bellanti JA; Settipane RA
    Allergy Asthma Proc; 2021 Sep; 42(5):365-367. PubMed ID: 34474705
    [No Abstract]   [Full Text] [Related]  

  • 80. Looking inside the 'black box' of vaccine hesitancy: unlocking the effect of psychological attitudes and beliefs on COVID-19 vaccine acceptance and implications for public health communication.
    Barello S; Palamenghi L; Graffigna G
    Psychol Med; 2023 Feb; 53(3):1120-1121. PubMed ID: 33678206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.